ASPCF - Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q4 2020 Results - Earnings Call Transcript
Acerus Pharmaceuticals Corporation (ASPCF) Q4 2020 Earnings Conference Call March 11, 2021 10:00 ET Company Participants Bob Motz - Chief Financial Officer Ed Gudaitis - President & Chief Executive Officer Conference Call Participants Presentation Operator Good morning, ladies and gentlemen, and welcome to the Fourth Quarter Conference Call for Acerus Pharmaceuticals Corporation. At this time, all participants are in listen-only mode. A brief question-and-answer session will follow this discussion. [Operator Instructions] I will now turn the call over to Mr. Bob Motz, Chief Financial Officer of Acerus Pharmaceuticals Corporation. Mr. Motz will moderate today's call. Mr. Motz, please proceed. Bob Motz Thank you very much, Melanie, and good morning and welcome, everybody, to the Acerus 2020 Fourth Quarter Conference Call. I'm pleased to be joined today virtually by Ed Gudaitis, our President and Chief Executive Officer; as well as Dr. Christopher Sorli, our Chief Medical Officer; Kevin Hickey, our Senior
For further details see:
Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q4 2020 Results - Earnings Call Transcript